News

Published on 10 Jan 2022 on Benzinga

45 Stocks Moving In Monday's Mid-Day Session

Article preview image

Check out these big penny stock gainers and losers

Read the rest of the article
NYSE.QTWO price evolution
NASDAQ.LHDX price evolution
NYSE.MYE price evolution
NYSE.STEM price evolution
NASDAQ.BCRX price evolution
NASDAQ.FOLD price evolution
NASDAQ.PXLW price evolution
NASDAQ.CDNA price evolution
NYSE.BILL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)

Director Margaret Mcglynn has sold 15,000 shares of Amicus Therapeutics Inc (NASDAQ:FOLD) on Marc...

GuruFocus.com via Yahoo Finance 7 Mar 2024
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their...

Last week saw the newest full-year earnings release from Amicus Therapeutics, Inc. (NASDAQ:FOLD),...

Simply Wall St. via Yahoo Finance 2 Mar 2024
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus...

Insider Monkey via Yahoo Finance 29 Feb 2024
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates

Amicus Therapeutics, Inc. FOLD reported fourth-quarter 2023 adjusted earnings of 1 cent per share...

Zacks via Yahoo Finance 29 Feb 2024
Amicus (FOLD) Issues Preliminary Revenue Results for FY23

Amicus Therapeutics, Inc. FOLD announced preliminary results for the fourth quarter and full-year...

Zacks via Yahoo Finance 8 Jan 2024
Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 15,833 Shares

On January 2, 2024, Bradley Campbell, President and CEO of Amicus Therapeutics Inc (NASDAQ:FOLD),...

GuruFocus.com via Yahoo Finance 5 Jan 2024
Even after rising 4.3% this past week, Amicus Therapeutics (NASDAQ:FOLD) shareholders are still down...

This month, we saw the Amicus Therapeutics, Inc. (NASDAQ:FOLD) up an impressive 32%. But that doe...

Simply Wall St. via Yahoo Finance 30 Dec 2023
Amicus Therapeutics Inc's Chief Development Officer Sells Shares

On December 28, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ...

GuruFocus.com via Yahoo Finance 30 Dec 2023
Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares

Amicus Therapeutics Inc (NASDAQ:FOLD), a biotechnology company focused on discovering, developing...

GuruFocus.com via Yahoo Finance 29 Dec 2023
Amicus Therapeutics Inc's Chief Development Officer Sells Shares

On December 20, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ...

GuruFocus.com via Yahoo Finance 21 Dec 2023

Copyright Statfolio @ 2024

Social Accounts